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Abstract This study was designed to examine the inﬂu-
enceofintegrinsubunit-b1andsubunit-b3onthebehaviorof
primaryosteoblast-like cells, cultured on calcium phosphate
(CaP)-coated and non coated titanium (Ti). Osteoblast-like
cells were incubated with speciﬁc monoclonal antibodies
against integrin-b1 and integrin-b3 to block the integrin
function. Subsequently, cells were seeded on Ti discs, either
non coated or provided with a 2 lm carbonated hydroxy-
apatitecoatingusingElectrostaticSprayDeposition.Results
showed that on CaP coatings, cellular attachment was
decreased after a pre-treatment with either anti-integrin-b1
oranti-integrin-b3antibodies.OnTi,celladhesion wasonly
slightly affected after a pre-treatment with anti-integrin-b3
antibodies. Scanning electron microscopy showed that on
bothtypesofsubstrate,cellularmorphologywasnotchanged
after a pre-treatment with either antibody. With quantitative
PCR,itwasshownforbothsubstratesthatmRNAexpression
ofintegrin-b1wasincreasedafterapre-treatmentwitheither
anti-integrin-b1oranti-integrin-b3antibodies.Furthermore,
afterapre-treatmentwitheitherantibody,mRNAexpression
of integrin-b3 and ALP was decreased, on both types of
substrate.Inconclusion,osteoblast-likecellshavetheability
to compensate to great extent for the blocking strategy as
applied here. Still, integrin-b1 and b3 seem to play different
roles in attachment, proliferation, and differentiation of
osteoblast-likecells,andresponsesonCaP-coatedsubstrates
differ to non coated Ti. Furthermore, the inﬂuence on ALP
expressionsuggestsinvolvementofbothintegrinsubunitsin
signal transduction for cellular differentiation.
Introduction
For implants used in orthopedic or dental surgery the
implant-to-bone contact is inﬂuenced by the characteristics
of the implant, like the surface structure and chemical
composition. Regarding the latter, calcium phosphate
(CaP) coatings have shown to favor the bone response
in vivo [1, 2]. However, the mechanism responsible for the
improved osteogenic response to CaP coatings is still not
clear. Studying the mechanism in vivo is complicated by
many factors. Still, cell culture models can be designed to
study (parts of) the underlying mechanisms.
Invitro,itisknownthatcellsattachtoextracellularmatrix
(ECM) proteins, which are adsorbed to the surface of the
material. Speciﬁc transmembrane proteins, called integrins,
connect the cells to the ECM proteins. These integrins con-
sist of an a- and a b-unit. Osteoblasts generally express
integrinsubunitsa1,a2,a3,a4,a5,a6,av,b1,b3,andb5[3].
In Table 1, an overview is listed of combinations of integrin
subunits and their protein ligands [4]. Important ECM pro-
teins for the attachment of osteoblasts are ﬁbronectin, col-
lagen type I, and vitronectin. For attachment to ﬁbronectin
andcollagentypeI,osteoblastscanexpressintegrinsubunit-
b1. For attachment to vitronectin, they may use integrin
subunit-b3[ 5]. Once cells have attached, the integrin is also
involved in passing information from the ECM to the cell
(‘‘outside-in-signaling’’),andfromthecelltowardstheECM
(‘‘inside-out-signaling) [6]. These signaling pathways can
regulate cellular adhesion, migration, and subsequent
behavior to a great extent.
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implant-interface was examined on two different implant
materials (either CaP-coated or non coated Ti), with the
functional blocking of integrins. We hypothesize that
blocking integrin-b1 and integrin-b3 with speciﬁc anti-
bodies will have an inhibitory effect on the initial attach-
ment, and thus will delay proliferation and early
differentiation of osteoblast-like cells. Furthermore, we
hypothesize that differences in cellular response exist
between cultures on CaP coatings and non coated Ti. For
this purpose, carbonated hydroxyapatite (HA) coatings
were deposited with the electrostatic spray deposition
(ESD) technique. Subsequently, anti-integrin-b1 and anti-
integrin-b3 antibodies were added to primary osteoblast-
like cells, and cells were cultured on both substrates. The
initial cellular attachment, proliferation, and cell shape
were evaluated. Further, gene expression for integrins b1
and b3, and alkaline phosphatase, was examined with
quantitative PCR. Results were compared to cultures
without antibodies added to the cells on both materials.
Materials and methods
Substrates
Disc-shaped commercially pure (cp) Ti substrates with a
diameter of 12 mm and a thickness of 1.5 mm were cleaned
ultrasonically in isopropanol for 5 min. Subsequently, the
substrates were not coated, or provided with a CaP coating
using the ESD technique.
The ESD coating procedure was performed using a ver-
tical ESD set-up (Advanced Surface Technology, Bleiswijk,
The Netherlands) with a two component-nozzle, as de-
scribed previously [7, 8]. The solvents for the coating con-
sisted of 6.25 mM Ca(NO3)2  2H2O and 3.5 mM H3PO4 in
butyl carbitol. The applied voltage was 6.3–6.4 kV, the ﬂow
rate 1 mL per hour per solvent, the deposition time 45 min,
and the substrate temperature 350  C. The nozzle-to-sub-
strate distance was 20 mm. The deposited coatings had a
thickness of 2 lm. After deposition, the substrates were
subjected to an additional heat-treatment for 2 h at a tem-
perature of 700  C in air to crystallize the coating. After the
heat-treatment, coatings were characterized by X-ray dif-
fraction, Fourier-transform infrared, and scanning electron
microscopy combined with electron dispersive spectros-
copy, as crystalline carbonated hydroxyapatite, with a Ca/P
ratio of 1.9–2.0 and a uniform porous surface morphology.
Beforeuseintheinvitroassays,allsubstratesweresterilized
15 min at 121  C in an autoclave.
Cell culture
Rat bone marrow (RBM) cells were isolated and cultured
to obtain osteoblast-like cells, using a method adapted from
Maniatopoulos et al. [9]. For each individual run, RBM
cells were obtained from both femora of one male Wistar
WU rat (40–43 days old). Femora were washed four times
in alpha-Minimal Essential Medium (a-MEM; Gibco BRL,
Life Technologies B.V. Breda, The Netherlands) with
0.5 mg/mL gentamycin and 3 lg/mL fungizone. Epiphyses
were cut off and diaphyses ﬂushed out with 30 mL culture
medium (a-MEM, supplemented with 10% fetal calf serum
(FCS; Gibco), 50 lg/mL ascorbic acid (Sigma, Chemical
Co., St. Louis, MO, USA), 50 lg/mL gentamycin, 10 mM
Na-b-glycerophosphate (Sigma), and 10
–8 M dexametha-
sone (Sigma)). The ﬂush-out of both femora was pooled
and divided over three culture ﬂasks (75 cm
2). Cells were
incubated in a humidiﬁed atmosphere of 95% air, 5% CO2
at 37  C. After 7 days of primary culture osteoblast-like
cells were detached using trypsin/EDTA (0.25% w/v
trypsin/0.02% EDTA).
Blocking with speciﬁc antibodies
Integrin blocking was applied as described by McNally
et al. [10]. Osteoblast-like cells were concentrated by cen-
trifugation (350 g, 5 min), counted with a Coulter
  Counter
(Coulter Electronics Ltd., Luton, United Kingdom),
concentrated by centrifugation (1,500 rpm, 5 min), and
resuspended to a concentration of 1.5 · 10
6 cells in 1 mL
Table 1 An overview of possible integrin subunits and their protein
ligands [2]
Subunits Ligands
b1 a1 Collagens, Laminins
a2 Collagens, Laminins
a3 Fibronectin, Collagen, Laminin
a4 Fibronectin, VCAM
a5 Fibronectin
a6 Laminins
a7 Laminins
a8 Fibronectin
a9 Tenascin, Osteopontin
Av Fibronectin, Vitronectin
b2 AL ICAMs
aM Fibrinogen
AX Fibrinogen
b3 Iib Fibrinogen, Fibronectin, Vitronectin
Av Fibrinogen, Fibronectin, Vitronectin, BSP
b4 a6 Laminin
b5 Av Vitronectin
b6 Av Fibronectin
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monoclonal anti-integrin-b1 antibodies or anti-integrin-b3
antibodies (Ha2/5 or 2C9.G2, respectively, both from BD
Biosciences Pharmingen, NJ, USA) were added to the cells
in a concentration of 50 lg/mL. The experimental groups
were incubated at 4  C for 30 min to allow antibodies to
interact with the integrins on the osteoblast-like cells. The
control group consisted of osteoblast-like cells without
antibodies added, and was also incubated at 4  C for
30 min.
Cell seeding
After 30 min of incubation with or without integrin anti-
bodies, cells were concentrated by centrifugation (350 g,
5 min) and resuspended in culture medium. Cells were
again counted with a Coulter
  Counter, and seeded on the
substrates at a concentration of 11,500 cells per cm
2.
Initial attachment and total cell amount
After 30, 60, 120, and 240 min of incubation, and 1 and 3
days of culture, substrates were washed with PBS to
remove all non-adherent cells, and placed in a new 24-well
plate. Attached cells were released from the substrate with
0.5 mL trypsin/EDTA. After 5 min of incubation in 37  C,
0.5 mL culture medium was added to block the enzymatic
activity of the trypsin, and cells were counted with a
Coulter
  Counter. Cellular attachment was normalized to
the values of the control group after 30 min of incubation
on the relevant substrate (set at 100%). All substrates were
routinely observed with light microscopy, to conﬁrm the
efﬁcacy of the detachment procedure.
Scanning electron microscopy (SEM)
To observe changes in cell morphology, SEM was per-
formed after 1 and 3 days of culture. Substrates were
washed twice with PBS, and ﬁxation was carried out for
5 min in 2% gluteraldehyde. Subsequently, substrates were
washed with 0.1 M sodium-cacodylate buffer (pH 7.4),
dehydrated in a graded series of ethanol, and dried in tet-
ramethylsilane. The substrates were sputter-coated with
gold and examined using a Jeol 6310 SEM (Tokyo, Japan).
Real time quantitative RT-PCR
The gene expression for integrins b1 and b3, and alkaline
phosphatase was also examined. After 1 and 3 days of
culture, RNA was isolated from the cells using a RNA
isolation kit (Qiagen, Hilden, Germany). After the isolation
of the RNA, the reverse transcriptase (RT)-reaction was
performed. The cDNA from the RT-reaction was used as a
template in the polymerase chain reaction (PCR). To per-
form quantitative PCR, 4.5 lL RNase-free water, 12.5 lL
SYBR
  Green MasterMix (Eurogentec, Liege, Belgium),
5 lL cDNA, 1.5 lL Reverse Primer and 1.5 lL Forward
Primer were added to a QRT-PCR-96-well plate. This plate
was sealed, and the Q-PCR-run was performed with the
MyiQ Single-Color Real-Time Detection System for
quantiﬁcation with SYBR
  Green and melting curve
analysis (Biorad, Richmond, CA, USA). DNA was PCR-
ampliﬁed under the following conditions: 2 min at 50  C
and 10 min at 95  C, followed by 40 cycles of 15 s at
95  C and 1 min at 60  C, with data collection in the last
30 s. The used primers are listed in Table 2. The reference
household-gene used to normalize the amount of mRNA in
the cultures was GAPDH (DCT=CT,gene of interest –C T,GAPDH
(1)). Gene expression was measured relative to the gene
expression of cultures on the relevant substrates (either
CaP-coated or non coated Ti) that had not received anti-
bodies, after day 1 of culture (DDCT=DCT,sample –
DCT,control (2)). The fold change in gene expression relative
to the control was calculated by 2
–DDCT (3) [11].
Statistical analysis
All assays were performed in triplicate. Statistical analysis
for initial attachment and total cell amount was performed
using a two-way ANOVA. As post-hoc comparison, a
Tukey test was performed. A probability (P) value less than
0.05 was considered statistically signiﬁcant. The experi-
ments was replicated multiple times, but only the two
independent experiments which were most representative
for the results obtained overall are presented in the current
investigation, and hereafter termed ‘run 1’ and ‘run 2’.
Results
Initial attachment and total cell amount
CaP-coated substrates
In the ﬁrst run, the initial cellular attachment was decreased
after 30 min for ±30% after a pre-treatment with anti-in-
tegrin-b1 antibodies (P < 0.05). With a pre-treatment of
anti-integrin-b3 antibodies, initial attachment was de-
creased for ±40% after 30 and 60 min (P < 0.01) (Fig. 1A,
B). In the second run, a pre-treatment with anti-integrin-b1
antibodies gave a reduction of ±20–30% in cellular
attachment after 60 and 240 min, and after 1 day
(P < 0.05). A pre-treatment with anti-integrin-b3 antibod-
ies decreased cellular attachment for 40–50% after 30
(P < 0.01), 60, 240 min (P < 0.05), 1 day (P < 0.01), and
3 days (P < 0.05) (Fig. 2A, B).
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In general, integrin blocking had a less effect on the bare Ti
substrates. In the ﬁrst run, no differences were observed in
initial cellular attachment or cell number with a pre-treat-
ment of anti-integrin-b1 or anti-integrin-b3 antibodies,
although the means are quite different. Possibly, if the error
were smaller, it would emerge that the function blocking
antibodies were indeed effective (Fig.1C, D). However,
also in the second run, no differences in initial attachment
were observed with the pre-treatment of anti-integrin-b1
antibodies. However, with a pre-treatment of anti-integrin-
b3 antibodies, a decrease of ±30% in attachment was seen
after 30 and 60 min (P < 0.05) (Fig. 2C, D).
SEM
CaP-coated substrates
In both runs, osteoblast-like cells on CaP-coated substrates
had attached and spread over the substrate surface after 1
day of culture (Fig. 3A). Cells exhibited a typical pheno-
type for osteoblasts in culture, i.e. a ﬂat monolayer with
multiple cell extensions, and frequent cell-to-cell contact.
After 3 days of culture, cells were more elongated and
more numerous. Pre-treatment with either anti-integrin-b1
antibodies (Fig. 3B) or anti-integrin-b3 antibodies
(Fig. 3C) did not noticeably change cellular morphology
upon visual inspection.
Non coated Ti substrates
On non coated Ti-substrates, osteoblast-like cells were also
stretched out over the surface after 1 day of culture
(Fig. 3D). After 3 days, more cells were present, which
were well spread. After pre-treatment with both speciﬁc
antibodies (Fig. 3E, F), no changes in morphology were
observed, after both 1 and 3 days of culture.
Real time quantitative RT-PCR
Real time quantitative RT-PCR (QRT-PCR) was per-
formed to determine the gene expression relative to the
control group (cell culture without a pre-treatment with
integrin antibodies). The results of QRT-PCR are listed in
Table 3.
mRNA expression of integrin-b1 on CaP-coated substrates
In the control groups, mRNA expression of integrin-b1
increased from day 1 to day 3. In the ﬁrst run, after a
Table 2 Overview of the ampliﬁcation primers used for QRT-PCR
Forward primer Reverse primer
integrin-b15 ¢TGGTCAGCAGCGCATATCTG3¢ 5¢TGCATCAAAGCCACCTTCTG3¢
integrin-b35 ¢CCACTGATGCCAAGACCCATA3¢ 5¢AGACAATGCCTGCCAGCCT3¢
ALP 5¢GCTTCACGGCATCCATGAG3¢ 5¢GAGGCATACGCCATGACGT3¢
GAPDH 5¢GCTTTGTGCAGTGCCAGCC3¢ 5¢CACCGACCTTCACCATCTTGT3¢
Fig. 1 Cellular attachment in
the ﬁrst run. (A) and (B) CaP-
coated substrates derived with
Electrostatic Spray Deposition
(ESD); (C) and (D) non-coated
Ti. * indicates a signiﬁcant
difference between the control
group and the experimental
group with the pre-treatment
with anti-integrin-b1 antibodies.
# indicates a signiﬁcant
difference between the control
group and the experimental
group that was pre-treated with
anti-integrin-b3 antibodies
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b3 antibodies, mRNA of integrin-b1 was increased, com-
pared to the control group, after 1 and 3 days of culture
(Table 3). In the second run, a similar increase was seen,
which however was delayed until day 3 for both experi-
mental groups.
Fig. 2 Cellular attachment in
the second run. (A) and (B)
CaP-coated substrates derived
with Electrostatic Spray
Deposition (ESD); (C) and (D)
non-coated Ti. * indicates a
signiﬁcant difference between
the control group and the
experimental group with the
pre-treatment with anti-integrin-
b1 antibodies.
# indicates a
signiﬁcant difference between
the control group and the
experimental group that was
pre-treated with anti-integrin-b3
antibodies
Fig. 3 Scanning electron
micrographs of osteoblast-like
cells on CaP-coated (A, B, and
C) substrates, and non-coated
(D, E, and F) Ti substrates after
1 day of culture. There were no
morphological differences
between the control group (A
and D), or the experimental
groups that were either pre-
treated with anti-integrin-b1
antibodies (B and E), or anti-
integrin-b3 antibodies (C and F)
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substrates
Also on the bare Ti, the mRNA expression of integrin-b1
was increased in the control group after 3 days of culture.
In the ﬁrst run, a pre-treatment with anti-integrin-b1 anti-
bodies increased the mRNA expression of integrin-b1.
A pre-treatment with anti-integrin-b3 antibodies also gave
an increase in mRNA of integrin-b1 (Table 3). In the
second run similar trends were seen. However, now the
increase was delayed, either after a pre-treatment with anti-
integrin-b1 or anti-integrin-b3 antibodies.
mRNA expression of integrin-b3 on CaP-coated substrates
Opposite to the expression of integrin-b1, the mRNA
expression of integrin-b3 was decreased on the control
sample after 3 days of culture. In both performed runs, a
pre-treatment with either anti-integrin-b1 or anti-integrin-
b3 antibodies decreased the mRNA of integrin-b3, after 1
and 3 days of culture (Table 3).
mRNA expression of integrin-b3 on non coated Ti
substrates
In the ﬁrst run, the control group had a decreased mRNA
expression of integrin-b3 after 3 days of culture. After a
pre-treatment of the cells with anti-integrin-b1 antibodies,
mRNA of integrin-b3 was increased after 1 day, but
decreased after 3 days of culture. A pre-treatment with
anti-integrin-b3 antibodies decreased mRNA of integrin-b3
after 1 and 3 days of culture. In the second run, mRNA of
integrin-b3 in the control group was increased from day 1
to day 3. A pre-treatment with anti-integrin-b1 antibodies
increased mRNA of integrin-b3 after 1 day of culture, and
decreased after 3 days of culture. After a pre-treatment
with anti-integrin-b3 antibodies, mRNA expression of
integrin-b3 was increased after both 1 and 3 days of culture
(Table 3).
mRNA expression of ALP on CaP-coated substrates
The mRNA expression of ALP in the control group
decreased from day 1 to day 3. A pre-treatment of the cells
Table 3 mRNA expression. Listed are the normalized changes (percentages) in mRNA expression of integrins-b1 and 3, and ALP, relative to
the control group after 1 day of culture on both types of substrate
MRNA expression of integrin-b1 (percentages)
run 1 run 2
day 1 day 3 day 1 day 3
CaP-coated control 100 134 100 492
anti-integrin-b1 570 220 84 513
anti-integrin-b3 453 196 107 566
Ti control 100 243 100 392
anti-integrin-b1 222 554 154 636
anti-integrin-b3 320 426 145 794
mRNA expression of integrin-b3 (percentages)
CaP-coated control 100 19 100 14
anti-integrin-b1 71 8 50 21
Anti-integrin-b3 41 9 30 15
Ti control 100 39 100 140
anti-integrin-b1 149 12 817 91
anti-integrin-b3 48 10 673 701
mRNA expression of ALP (percentages)
CaP-coated control 100 49 100 50
Anti-integrin-b1 84 4 92 33
Anti-integrin-b3 73 1 17 31
Ti control 100 50 100 20
Anti-integrin-b1 127 4 58 4
Anti-integrin-b38 6 3 9 2 5
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decreased the mRNA of ALP after 1 and 3 days of culture
(Table 3).
mRNA expression of ALP on non coated Ti substrates
In the control group, mRNA expression of ALP was
decreased from day 1 to day 3. A pre-treatment with anti-
integrin-b1 antibodies decreased the mRNA expression of
ALP. A decrease in mRNA of ALP was also observed after
a pre-treatment with anti-integrin-b3 antibodies (Table 3).
Discussion and conclusion
Integrins are involved in the attachment of cells to the pro-
teinsthatareadsorbedtothesurfaceofasubstrateorimplant
[3, 4]. Furthermore, they are relevant for the signaling of the
ECM with the cell and of the cell with the ECM, inﬂuencing
cellular behavior [5, 6]. This study examined the effects of
blockingintegrin-b1orintegrin-b3withspeciﬁcmonoclonal
antibodiesonthecellularbehaviorofprimaryosteoblast-like
cells cultured on an ESD-derived CaP coating, or on non
coated Ti substrates. The results showed an affected initial
attachment,andanalteredmRNAexpressionofintegrin-b1,
integrin-b3, and ALP, when the function of integrin-b1o r
integrin-b3 was inhibited.
First, general remarks have to be made regarding the
method used to block the integrins. Osteoblast-like cells
were pre-treated with monoclonal antibodies in PBS/BSA
0.5% and incubated at 4  C for 30 min, as previously
employed by multiple researchers [10, 12, 13]. No serum
was added to the cell suspension while the antibodies were
incubated to avoid competitive binding of the antibodies
with serum proteins. In contrast, another study describes
the addition of antibodies to the cells, in complete culture
medium after seeding them on the substrates [14]. Using
this latter method, the antibodies only inﬂuenced cell sig-
naling, as cells had already adhered. In the present study,
the antibodies were added in suspension before cell seeding
on the substrates. Using this method, all integrins on the
surface were blocked, affecting the function of integrins in
both attachment and cell signaling. Moreover, in the cur-
rent study blocking antibodies were used at a concentration
of 50 lg/mL, which is very likely to be a saturating con-
centration. However, at high antibody concentrations, even
nonspeciﬁc IgGs could possibly have had some inhibitory
effect on cell adhesion. For future experiments, isotype-
matched nonspeciﬁc IgGs should be studied also to control
for nonspeciﬁc effects. However, such future studies on a
comparative analysis of the functions of integrin-b1 versus
integrin-b3 could also concentrate on other methods
besides blocking the function with antibodies. General
disadvantages of antibody blocking procedures are that the
binding afﬁnities, as well as the expression level can differ
between the two integrins. More conclusive studies could
be performed to compare the functions of integrin-b1 and
integrin-b3, like using knock-out animals or siRNA tech-
niques. Such studies then should encompass not only
transcription (as studied here) but be complemented by
experiments verifying that integrin protein expression
changes (e.g. Western blots or ﬂow cytometry). Integrins
are highly regulated at many levels; transcriptional, trans-
lational, and post-translational. It is well established that
changes in integrin mRNA levels do not always translate to
greater integrin protein expression and/or activity.
Concerning the overall study results, it is evident that
differences exist between the two performed runs. Several
explanations can be given for these observations. First, it is
known that integrin expression is a very dynamic process
[15–18]. Furthermore, the proteins adsorbed to the surface
are not immobile, and the cell itself produces ECM pro-
teins, which inﬂuence the integrin expression. Finally,
there might be variability between the heterogeneous cell
populations of both runs. However, this in vitro-research
was designed to determine the importance of integrins in
the behavior of primary osteoblast-like cells. Despite the
differences between the two runs, the same tendency was
observed, conﬁrming that the results are reliable.
CaP-coated and plain Ti materials are both commonly
used for the production of dental implants. However,
studies have shown a beneﬁcial osteogenic effect of CaP-
coated surfaces, compared to Ti [19–21]. Studies attempt-
ing to clarify the mechanism behind these beneﬁcial effects
have shown that both the chemical composition and surface
roughness are of inﬂuence on protein adsorption, integrin
expression, and subsequently cellular behavior [22–24]. In
the present study, the substrates differ in chemical com-
position, roughness, and morphology, and thus it is not
possible to attribute effects on cell behavior to just one of
these factors. Therefore, we separated the results of cell
cultures on CaP-coated from non coated Ti substrates.
Intheﬁrstrun,cellularattachmentearlyafterseedingwas
affected on CaP-coated substrates following a pre-treatment
with anti-integrin-b1 or anti-integrin-b3 antibodies. Fur-
thermore, mRNA expression of integrin-b1 was increased,
and the mRNA expression of integrin-b3 was decreased. In
the second run, initial attachment and total cell amount were
decreased when cells were pre-treated with anti-integrin-b1
oranti-integrin-b3antibodies.Moreover,mRNAexpression
of integrin-b1 was increased after 3 days of culture, and
mRNA expression of integrin-b3 was decreased, even in the
control groups. From these data, it can be deducted that on
the ESD-derived CaP-coated substrates mainly integrin-b1
is responsible for cellular attachment. These results corrob-
orate the available literature, which shows that integrin-b1
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whereas integrin-b3 is not always present [15–18]. Indeed,
many researchers state that integrin-b1 is the major subunit
in osteoblasts [5, 25, 26].
On non coated Ti substrates, cellular attachment was not
affected by the blocking procedure in the ﬁrst run. Still,
mRNA expression of integrin-b1 was upregulated, and
mRNA of integrin-b3 was decreased. In the second run,
again attachment was not affected by a pre-treatment with
anti-integrin-b1 antibodies. However, early cellular attach-
ment was decreased when cells were pre-treated with
anti-integrin-b3 antibodies. The mRNA expression of inte-
grin-b1wasincreasedafter3 daysofculture,andthemRNA
of integrin-b3 was increased after 1 day of culture. These
results suggest an involvement of integrin-b1 and integrin-
b3intheattachmentofosteoblast-likecellstononcoatedTi.
However,intheﬁrstrun,thereisonlyasmallupregulationof
mRNA of integrin-b1, and no effect on cellular attachment,
whichistheoppositeoftheresultsonCaP-coatedsubstrates.
Furthermore, in the second run, an increased mRNA of in-
tegrin-b3 was observed, but a decrease in early cellular
attachment. On bare Ti, osteoblast-like cells have a consid-
erable ability to compensate for cellular attachment, for
example with the upregulation of other integrins.
Besides their role as adhesion molecule, integrins also
function as signaling receptors. Integrin-b1-mediated
adhesion to bone matrix induces proliferation, differentia-
tion, and matrix synthesis by osteoblasts [27]. In the
present study, after a pre-treatment with either integrin
antibody, the mRNA expression of ALP was decreased.
This occurred in both runs, and on both types of substrates.
Thus it seemed that, despite the increase in mRNA of in-
tegrin-b1 and integrin-b3, signal transduction necessary for
osteogenic differentiation was decreased or at least
delayed. It has to be noted that without a pre-treatment with
anti-integrin-b1 or anti-integrin-b3 antibodies, mRNA
expression of ALP was also decreased in cultures on both
types of substrates, when day 1 is compared to day 3. These
results are supported by other studies. For instance, a
decreased ALP activity was observed when antibodies
against ﬁbronectin (a4b1 and a5b1) or collagen type I
(a1b1 and a2b1) were added [14].
In conclusion, we can maintain our hypothesis that
blocking of integrin-b1 and integrin-b3 with antibodies has
an inhibitory effect on the attachment and differentiation of
osteoblast-like cells. However,osteoblast-like cells have the
abilitytocompensatetogreatextentfortheblockingstrategy
as applied here. Still, integrin-b1 and b3 seem to play dif-
ferent roles in attachment, proliferation, and differentiation
of osteoblast-like cells, and responses on CaP-coated sub-
strates differ to non coated Ti. Furthermore, the inﬂuence on
ALP expression suggests involvement of both integrin
subunits in signal transduction for cellular differentiation.
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